ResearcherJohns Hopkins UniversityActive in the last 2 years
Yao Xu
Matched on ORCID iD 0000-0003-2171-3731; OpenAlex author ID A5100656918. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 36
2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 5
- CD137 agonism enhances anti-PD1 induced activation of expanded CD8+ T cell clones in a neoadjuvant pancreatic cancer clinical trial. Co-author DOI 10.1016/j.isci.2024.111569↗
- CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2023.06.037↗
- Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model. Co-author DOI 10.1016/j.canlet.2022.215722↗
- CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma. Co-author DOI 10.1084/jem.20211631↗
- Inhibition of focal adhesion kinase enhances antitumor response of radiation therapy in pancreatic cancer through CD8+ T cells. Co-author DOI 10.20892/j.issn.2095-3941.2020.0273↗
Closest collaborators
The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lei Zheng · 5 shared papers, 2021–2025 · strength 0.64
- Paper CD137 agonism enhances anti-PD1 induced activation of expanded CD8+ T cell clones in a neoadjuvant pancreatic cancer cl… DOI 10.1016/j.isci.2024.111569↗
- Paper CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic… DOI 10.1053/j.gastro.2023.06.037↗
- Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
- Nan Niu · 4 shared papers, 2021–2023 · strength 0.48
- Paper CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic… DOI 10.1053/j.gastro.2023.06.037↗
- Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
- Paper CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma. DOI 10.1084/jem.20211631↗
- Brian T. Herbst · 3 shared papers, 2021–2022 · strength 0.34
- Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
- Paper CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma. DOI 10.1084/jem.20211631↗
- Paper Inhibition of focal adhesion kinase enhances antitumor response of radiation therapy in pancreatic cancer through CD8+ … DOI 10.20892/j.issn.2095-3941.2020.0273↗
- Keyu Li · 3 shared papers, 2021–2022 · strength 0.34
- Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
- Paper CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma. DOI 10.1084/jem.20211631↗
- Paper Inhibition of focal adhesion kinase enhances antitumor response of radiation therapy in pancreatic cancer through CD8+ … DOI 10.20892/j.issn.2095-3941.2020.0273↗
- Junke Wang · 2 shared papers, 2022–2023 · strength 0.25
- Paper CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic… DOI 10.1053/j.gastro.2023.06.037↗
- Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
- Pan Li · 2 shared papers, 2022–2023 · strength 0.25
- Paper CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic… DOI 10.1053/j.gastro.2023.06.037↗
- Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
- Sophia Y. Chen · 2 shared papers, 2022–2023 · strength 0.25
- Paper CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic… DOI 10.1053/j.gastro.2023.06.037↗
- Paper CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma. DOI 10.1084/jem.20211631↗
- Stephen T. Muth · 2 shared papers, 2022 · strength 0.24
- Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
- Paper CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma. DOI 10.1084/jem.20211631↗
- Noah S Rozich · 2 shared papers, 2022 · strength 0.24
- Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
- Paper CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma. DOI 10.1084/jem.20211631↗
- Christopher L. Wolfgang · 2 shared papers, 2021–2022 · strength 0.23
- Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
- Paper Inhibition of focal adhesion kinase enhances antitumor response of radiation therapy in pancreatic cancer through CD8+ … DOI 10.20892/j.issn.2095-3941.2020.0273↗
- Arsen Osipov · 2 shared papers, 2021–2022 · strength 0.23
- Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
- Paper Inhibition of focal adhesion kinase enhances antitumor response of radiation therapy in pancreatic cancer through CD8+ … DOI 10.20892/j.issn.2095-3941.2020.0273↗
- Ding Ding · 2 shared papers, 2021–2022 · strength 0.22
- Paper CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma. DOI 10.1084/jem.20211631↗
- Paper Inhibition of focal adhesion kinase enhances antitumor response of radiation therapy in pancreatic cancer through CD8+ … DOI 10.20892/j.issn.2095-3941.2020.0273↗
- Eric Scott Christenson · 1 shared paper, 2025 · strength 0.17
- Dimitrios N. Sidiropoulos · 1 shared paper, 2025 · strength 0.17
- Robert A. Anders · 1 shared paper, 2025 · strength 0.17
- Jacob T. Mitchell · 1 shared paper, 2025 · strength 0.17
- Elana Judith Fertig · 1 shared paper, 2025 · strength 0.17
- Janelle Marie Montagne · 1 shared paper, 2025 · strength 0.17
- Luciane Tsukamoto Kagohara · 1 shared paper, 2025 · strength 0.17
- Elizabeth M. Jaffee · 1 shared paper, 2025 · strength 0.17
- Won Jin Ho · 1 shared paper, 2025 · strength 0.17
- Jacquelyn W. Zimmerman · 1 shared paper, 2025 · strength 0.17
- William Reece Burns · 1 shared paper, 2023 · strength 0.13
- Noelle R. Jurcak · 1 shared paper, 2023 · strength 0.13
- Jianxin Wang · 1 shared paper, 2022 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.